Vistagen Therapeutics (VTGN) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.42
-0.18
0.06
0.3

Details

Expected EPS
-0.390825
Actual EPS
-0.42
Surprise EPS
-0.03
Surprise Percent
+7.46%

Description

Vistagen Therapeutics (VTGN) has reported earnings of -0.42 per share for Q4 2024.

0 Comments

Share your thoughts